Recently, Zahra et al. presented a herceptin (HER2)-conjugated graphene biosensor that uses the special antibody of HER2, which turns this biosensor into an immunosensor for single-cell breast cancer detection. The gene discussed is ERBB2; the disease is breast carcinoma.